Takeda Pharmaceutical Co (BSP:TAKP34) EBIT per Share : R$4.69 (TTM As of Sep. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Takeda Pharmaceutical Co EBIT per Share?

Takeda Pharmaceutical Co's EBIT per Share for the three months ended in Sep. 2024 was R$2.26. Its EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2024 was R$4.69.

During the past 12 months, the average EBIT per Share Growth Rate of Takeda Pharmaceutical Co was 11.30% per year. During the past 3 years, the average EBIT per Share Growth Rate was -8.50% per year. During the past 5 years, the average EBIT per Share Growth Rate was 6.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Takeda Pharmaceutical Co's EBIT per Share or its related term are showing as below:

BSP:TAKP34' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -46.3 Med: 5.45 Max: 26.3
Current: -8.5

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Takeda Pharmaceutical Co was 26.30% per year. The lowest was -46.30% per year. And the median was 5.45% per year.

BSP:TAKP34's 3-Year EBIT Growth Rate is ranked worse than
74.52% of 836 companies
in the Drug Manufacturers industry
Industry Median: 6.8 vs BSP:TAKP34: -8.50

Takeda Pharmaceutical Co's EBIT for the three months ended in Sep. 2024 was R$7,276 Mil.

Takeda Pharmaceutical Co EBIT per Share Historical Data

The historical data trend for Takeda Pharmaceutical Co's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Takeda Pharmaceutical Co EBIT per Share Chart

Takeda Pharmaceutical Co Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

EBIT per Share

Get a 7-Day Free Trial

1.28

8.19

5.66

6.11

1.81

Takeda Pharmaceutical Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
EBIT per Share	Get a 7-Day Free Trial															-0.41	1.37	-1.04	2.11	2.26

Takeda Pharmaceutical Co EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Takeda Pharmaceutical Co's EBIT per Share for the fiscal year that ended in Mar. 2024 is calculated as

	EBIT per Share		(A: Mar. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	5727.92	/	3160.686
=	1.81

Takeda Pharmaceutical Co's EBIT per Share for the quarter that ended in Sep. 2024 is calculated as

	EBIT per Share		(Q: Sep. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	7276.067	/	3219.073
=	2.26

EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was R$4.69

Takeda Pharmaceutical Co (BSP:TAKP34) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Takeda Pharmaceutical Co EBIT per Share Related Terms

Thank you for viewing the detailed overview of Takeda Pharmaceutical Co's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Takeda Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Takeda Pharmaceutical Co Ltd (BSP:TAKP34) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

TAK:USA TKPHF:USA 4502:Japan 0A87:UK TKDA:Germany TKD:Austria

Address

1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, JPN, 103-8668

Website

https://www.takeda.com

Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.3 trillion in fiscal 2023. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the US, 20% from Japan, 20% from Europe and Canada.

Takeda Pharmaceutical Co Headlines

No Headlines